Honokiol, a biphenyl compound derived from magnolia bark, acts as a potent GABA receptor modulator and potential neuroinflammatory suppressant that may help mitigate the hyperactive neurological symptoms associated with Visual Snow Syndrome. By enhancing inhibitory neurotransmission and potentially reducing cortical hyperexcitability, honokiol could theoretically ameliorate the persistent visual disturbances characteristic of the syndrome through its neuroprotective and anxiolytic properties.